SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 21.24 |
| Enterprise Value ($M) | 39.90 |
| Book Value ($M) | -6.61 |
| Book Value / Share | -0.63 |
| Price / Book | -3.21 |
| NCAV ($M) | -18.62 |
| NCAV / Share | -1.78 |
| Price / NCAV | -1.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.16 |
| Return on Assets (ROA) | -0.68 |
| Return on Equity (ROE) | -4.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.36 |
| Current Ratio | 2.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27.32 |
| Assets | 39.33 |
| Liabilities | 45.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.91 |
| Operating Income | -44.54 |
| Net Income | -43.39 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -39.56 |
| Cash from Investing | 29.44 |
| Cash from Financing | 3.44 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Satterfield Thomas A Jr | 9.90 | 31.04 | |
| 13G | Bleichroeder LP | 9.90 | ||
| 13G/A | Maverick Capital Ltd | 8.00 | 17.02 | |
| 13G/A | Kingdon Capital Management, L.l.c. | 1.50 | -73.97 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 27,967 | 64,188 | 43.57 | |
| 46,584 | 125,570 | 37.10 | |
| 66,943 | 153,842 | 43.51 | |
| 77,750 | 199,870 | 38.90 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CPRX – Catalyst Pharmaceuticals, Inc. | CRBP – Corbus Pharmaceuticals Holdings, Inc. |
| CRDF – Cardiff Oncology, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. |